184 related articles for article (PubMed ID: 27041084)
1. The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature.
Sattin M; Towheed T
Curr Rheumatol Rev; 2016; 12(3):208-222. PubMed ID: 27041084
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
Westlake SL; Colebatch AN; Baird J; Curzen N; Kiely P; Quinn M; Choy E; Ostor AJ; Edwards CJ
Rheumatology (Oxford); 2011 Mar; 50(3):518-31. PubMed ID: 21071477
[TBL] [Abstract][Full Text] [Related]
3. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
4. The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.
Westlake SL; Colebatch AN; Baird J; Kiely P; Quinn M; Choy E; Ostor AJ; Edwards CJ
Rheumatology (Oxford); 2010 Feb; 49(2):295-307. PubMed ID: 19946022
[TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis.
Barnabe C; Martin BJ; Ghali WA
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):522-9. PubMed ID: 20957658
[TBL] [Abstract][Full Text] [Related]
6. Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Leporini C; Russo E; D Angelo S; Arturi F; Tripepi G; Peluso R; Grembiale RD; Olivieri I; De Sarro G; Ursini F
Rev Recent Clin Trials; 2018; 13(3):184-191. PubMed ID: 29542420
[TBL] [Abstract][Full Text] [Related]
7. Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity.
Marks JL; Colebatch AN; Buchbinder R; Edwards CJ
Cochrane Database Syst Rev; 2011 Oct; (10):CD008952. PubMed ID: 21975789
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation.
Stevenson M; Archer R; Tosh J; Simpson E; Everson-Hock E; Stevens J; Hernandez-Alava M; Paisley S; Dickinson K; Scott D; Young A; Wailoo A
Health Technol Assess; 2016 Apr; 20(35):1-610. PubMed ID: 27140438
[TBL] [Abstract][Full Text] [Related]
9. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
10. Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses.
Chen Y; Sun J; Yang Y; Huang Y; Liu G
Clin Rheumatol; 2016 Jan; 35(1):1-18. PubMed ID: 26573205
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.
Moots RJ; Naisbett-Groet B
Rheumatology (Oxford); 2012 Dec; 51(12):2252-61. PubMed ID: 22942404
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
Ann Rheum Dis; 2018 Jan; 77(1):98-103. PubMed ID: 28970215
[TBL] [Abstract][Full Text] [Related]
13. Awareness and perceived risk of cardiovascular disease among individuals living with rheumatoid arthritis is low: results of a systematic literature review.
Ghosh-Swaby OR; Kuriya B
Arthritis Res Ther; 2019 Jan; 21(1):33. PubMed ID: 30670075
[TBL] [Abstract][Full Text] [Related]
14. Golimumab: Review of the efficacy and tolerability of a recently approved tumor necrosis factor-α inhibitor.
Boyce EG; Halilovic J; Stan-Ugbene O
Clin Ther; 2010 Sep; 32(10):1681-703. PubMed ID: 21194591
[TBL] [Abstract][Full Text] [Related]
15. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.
Dixon WG; Symmons DP
Ann Rheum Dis; 2007 Sep; 66(9):1132-6. PubMed ID: 17251223
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis.
Bili A; Tang X; Pranesh S; Bozaite R; Morris SJ; Antohe JL; Kirchner HL; Wasko MC
Arthritis Care Res (Hoboken); 2014 Mar; 66(3):355-63. PubMed ID: 24023053
[TBL] [Abstract][Full Text] [Related]
17. Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis?
Danninger K; Hoppe UC; Pieringer H
Int J Rheum Dis; 2014 Jul; 17(6):606-11. PubMed ID: 24931356
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of switching to a second tumour necrosis factor-alpha inhibitor after discontinuation of a first tumour necrosis factor-alpha inhibitor in rheumatoid arthritis: a systematic literature review and meta-analysis.
Rémy A; Avouac J; Gossec L; Combe B
Clin Exp Rheumatol; 2011; 29(1):96-103. PubMed ID: 21269578
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.
Castro-Villegas C; Pérez-Sánchez C; Escudero A; Filipescu I; Verdu M; Ruiz-Limón P; Aguirre MA; Jiménez-Gomez Y; Font P; Rodriguez-Ariza A; Peinado JR; Collantes-Estévez E; González-Conejero R; Martinez C; Barbarroja N; López-Pedrera C
Arthritis Res Ther; 2015 Mar; 17(1):49. PubMed ID: 25860297
[TBL] [Abstract][Full Text] [Related]
20. Systematic Literature Review and Meta-analysis of Tumor Necrosis Factor-Alpha Experienced Rheumatoid Arthritis.
Wells AF; Curtis JR; Betts KA; Douglas K; Du EX; Ganguli A
Clin Ther; 2017 Aug; 39(8):1680-1694.e2. PubMed ID: 28734661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
